Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Omar Belmine, Cherki Mhamed, Damia FaresfiledCriticalOmar Belmine
Priority to MA41930ApriorityCriticalpatent/MA41930A1/en
Publication of MA41930A1publicationCriticalpatent/MA41930A1/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions
(AREA)
Medicines Containing Material From Animals Or Micro-Organisms
(AREA)
Abstract
L’invention concerne une composition pour traitement de la maladie du bayoud, qui attaque les palmiers dattiers.The invention relates to a composition for the treatment of bayoud disease, which attacks date palms.
MA41930A2018-02-012018-02-01
Composition for treatment of bayoud disease
MA41930A1
(en)
New polymorphic form of n- [2- (6-fluoro-1h-indol-3-yl) ethyl] -3- (2,2,3,3-tetrafluoropropoxy) benzylamine hydrochloride for the treatment of disease. alzheimer